Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $4.4650 (0.34%) ($4.4650 - $4.4650) on Wed. Sep. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.22% (three month average) | RSI | 37 | Latest Price | $4.4650(0.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -3.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -10.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XLRE(33%) PEJ(98%) SIL(98%) VT(72%) SDY(60%) | Factors Impacting IOVA price | IOVA will decline at least -2.61% in a week (0% probabilities). ICLN(-9%) IDRV(24%) IFRA(50%) IWD(54%) IWN(113%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.61% (StdDev 5.22%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-14.99(-435.72%) | Resistance Level | $5.43 | 5 Day Moving Average | $4.67(-4.39%) | 10 Day Moving Average | $4.96(-9.98%) | 20 Day Moving Average | $5.43(-17.77%) | To recent high | -48.8% | To recent low | 0.3% | Market Cap | $654m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |